The case for de-escalation in antimicrobial therapy: Time to change our strategy in the management of septic shock?

Intensive Care Medicine

Volumn 40, Issue 2, 2014, Pages 284-285

  Bassetti, Matteo ^a   Paiva, José Artur ^b   Masterton, Robert G ^c  

^a Servicio de Urologia   (Italy)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of the West of Scotland University Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

FEMALE; HUMAN; MALE; MORTALITY; NEOPLASMS; NEUTROPENIA; SEPSIS; SEPTIC SHOCK;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; NEOPLASMS; NEUTROPENIA; SEPSIS; SHOCK, SEPTIC;

EID: 84893858336     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-3166-7     Document Type: Editorial

References (7)

1. Masterton RG (2011) Antibiotic de-escalation. Crit Care Clin 27:149-162
2. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF et al (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159-177 (Pubitemid 46084814)
3. Silva BNG, Andriolo RB, Atallah AN, Salomão R (2013) De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev 3:CD007934
4. Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernández-Delgado E, Herrera-Melero I, Ortiz-Leyba C, Márquez-Vácaro JA (2013) De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. doi: 10.1007/s00134-013-3077-7
5. Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, Berger P, Duran S, Faucher M, Blache JL, Saillard C, Vey N, Leone M (2013) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med. doi: 10.1007/s00134-013-3148-9
6. Leggieri N, Rida A, François P, Schrenzel J (2010) Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside. Curr Opin Infect Dis 23:311-319
7. Shah DN, Yau R, Weston J, Lasco TM, Salazar M, Palmer HR, Garey KW (2011) Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. J Antimicrob Chemother 66:2146-2151